Machines and Molecules
Machines and Molecules hosts guests on topics from machine learning as well as bio-chemistry/biotech, and therefore bridges the gap between those worlds. The podcast covers three different categories - Knowledge, Solution and Network.
- Indexed episodes, last 90 days
- 1
- Latest publication
- Jul 8, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 8, 2026
Latest episodes
From Code to Cures: Mark DePristo on the Zero-to-One Biotech Journey (opens the original)
Read excerpt
Mark DePristo, former CEO of BigHat Biosciences, reveals why the best biotech innovation doesn't bolt on AI later but bakes it into research from day one. He shifts from scaling a clinical-stage antibody powerhouse to the nimble "zero-to-one" world of Ember AI Studios, where small teams leverage AI to solve overlooked deep-tech problems. Mark illustrates how embedding high-throughput experimental loops into design processes creates a rhythm that feels less like a lab experiment and more like a j
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.